NCT06432673View on ClinicalTrials.gov

The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

May 27, 2024

Study Completion Date

May 27, 2024

Conditions
Type2diabetes
Interventions
DRUG

ATR-258 Oral solution

Oral solution

DRUG

ATR-258 Oral capsule

Oral capsule

Trial Locations (1)

Unknown

Clinical Trial Consultants AB, Uppsala

Sponsors

Lead Sponsor

Atrogi AB
All Listed Sponsors
lead

Atrogi AB

INDUSTRY

NCT06432673 - The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers | Biotech Hunter | Biotech Hunter